Enterprise Technology
Pfizer and JPMorgan Prove Quantum Computing Works in 2026
By the NeuralWired Research Desk | Updated July 8, 2026
Pfizer cut a four month drug simulation down to days. JPMorgan Chase ran real stock portfolios on a 98 qubit quantum computer using actual market data, not a simulation. Quantum computing real world applications are no longer confined to conference keynotes and vendor slide decks. They are showing up, quietly and specifically, inside three industries: pharmaceuticals, financial services, and logistics.
This isn’t the “quantum computing will change everything” story you’ve read a dozen times since 2019. It’s narrower than that, and more useful because of it. Three companies, three named pilots, three sets of numbers you can check yourself.
In this article
- How Pfizer actually uses quantum physics in drug discovery
- JPMorgan’s 98 qubit portfolio experiment, explained
- DHL, Volkswagen, and the logistics pilots nobody’s hyping
- What the market data says about where this is headed
- The algorithm gap: why hardware is outrunning usefulness
- What CTOs and technical leaders should actually do
- Frequently asked questions
A quick correction, because accuracy matters here. You may have seen claims that Pfizer “saved 18 months” on simulation time, or that JPMorgan modeled “10,000 portfolio scenarios in seconds.” Neither figure appears in any primary source from Pfizer, XtalPi, or JPMorgan. What’s actually documented, and cited below, is arguably more interesting: a four month process cut to days, and a real 225 asset portfolio problem run on live trapped ion hardware. No inflation needed.
How Pfizer actually uses quantum physics in drug discovery
Here’s the part most coverage gets wrong: Pfizer isn’t running its drug discovery pipeline on a quantum computer. Not yet, anyway. What it’s doing is arguably more interesting, because it’s already working.
Pfizer partnered with XtalPi, a pharmaceutical tech company founded by MIT trained quantum physicists, on crystal structure prediction. It’s a quantum physics based computational technique, built on AI and cloud infrastructure rather than a standalone quantum processor, that predicts how a drug candidate’s molecules will arrange themselves in three dimensions before a single physical crystal is grown.
That prediction used to take up to four months. Through the XtalPi collaboration, it now takes a matter of days.
Pfizer describes crystal structure prediction as a process the team used to avoid attempting, given how long it took, and now runs on nearly every small molecule project. Bruno Hancock, Global Head of Materials Science, Pfizer, Groton CT (via Pfizer.com)
Hancock also notes that a single crystal structure prediction requires computing power roughly equivalent to one million laptops. That’s the kind of number that explains why the four month wait existed in the first place, and why shrinking it to days matters commercially, not just academically.
Separately, Pfizer’s internal AI and Digital Accelerator team has published research applying a digitized counterdiabatic version of the Quantum Approximate Optimization Algorithm to molecular docking, the process of predicting how a drug candidate binds to its target protein. As of the March 2025 paper, that work ran on GPU clusters simulating quantum behavior, not on live quantum hardware. Worth flagging plainly: this is AI plus quantum-inspired computation, not a production quantum computer. Conflating the two is the single most common inaccuracy in secondary coverage of this topic.
Pfizer isn’t alone. Merck and GlaxoSmithKline are running comparable quantum-adjacent drug discovery partnerships, which tells you this is a sector-wide bet, not a one-company experiment.
JPMorgan’s 98 qubit portfolio experiment, explained
If you want the single most citable data point in enterprise quantum computing right now, this is it. On July 1, 2026, JPMorgan Chase and Amazon’s AWS Center for Quantum Computing published research titled “Quantum-Informed Portfolio Selection,” and it’s the rare quantum paper that used real market data instead of synthetic test cases.
The team framed portfolio diversification as a graph theory problem (specifically, a Maximum Independent Set problem) and ran it on Quantinuum’s 98 qubit Helios trapped ion quantum computer, using actual correlation data from four major stock indices: the DAX, FTSE 100, S&P 100, and Nikkei 225, with as many as 225 individual assets.
The results are blunt about where quantum computing currently stands. Standalone QAOA, the algorithm most associated with near-term quantum optimization, failed completely on the two hardest indices, the S&P 100 and Nikkei 225, hitting a 0% success rate on its own. JPMorgan’s hybrid workaround, an algorithm called qReduMIS, achieved success probabilities of 0.40 on the S&P 100 and 0.95 on the Nikkei 225, with approximation ratios of 0.96 or better across all four indices.
That gap between “pure quantum failed” and “hybrid quantum worked” is the actual story. It’s not that quantum computers solved finance. It’s that a hardware ceiling (98 qubits couldn’t natively handle a 225 asset problem) forced a classical-quantum workaround that ended up working well.
Pistoia has credited JPMorgan’s access to NVIDIA GPU based supercomputing through Argonne National Laboratory as central to running the large-scale numerical studies behind its quantum optimization research. Marco Pistoia, Head of Global Technology Applied Research and Head of Quantum Computing, JPMorgan Chase (via JPMorganChase Technology Blog)
JPMorgan has since filed a patent for quantum-assisted portfolio selection, and on June 3, 2026, announced a research collaboration with Oxford Quantum Circuits and AMD to build a dedicated Quantum-AI Data Centre in London, giving its quantum team a permanent testing environment for hybrid applications. Goldman Sachs, HSBC, and BBVA are running comparable pilots with IBM, D-Wave, and QC Ware, so read this as a competitive race across Wall Street, not a JPMorgan exclusive.
DHL, Volkswagen, and the logistics pilots nobody’s hyping
Logistics gets less press than pharma or finance in the quantum conversation, which is strange, because the underlying math (vehicle routing, crew scheduling, warehouse allocation) is exactly the kind of combinatorial optimization problem quantum algorithms are theoretically suited for.
DHL is benchmarking quantum-hybrid vehicle routing solvers against classical solvers for last-mile delivery, which accounts for 40 to 50% of total logistics cost. On 50 to 100 stop delivery instances, quantum-hybrid approaches currently perform comparably to classical solvers, with an expected advantage as hardware and problem sizes scale up.
Volkswagen is the most-documented enterprise quantum optimization user in the world, running pilots since 2017 across traffic routing, paint-shop scheduling, and battery chemistry research. Its 2019 Lisbon bus-routing pilot was the first public urban traffic optimization test using quantum methods.
Qantas, Airbus, and IBM Quantum ran a proof-of-concept back in 2021 applying quantum computing to flight crew scheduling, widely considered one of aviation’s hardest combinatorial problems. More recently, Airbus and BMW ran a 2024 Quantum Computing Challenge tasking entrants with optimizing a global aircraft manufacturing supply network for cost, delivery time, and carbon emissions simultaneously. Lufthansa Cargo, Amazon, and Carrefour are testing similar approaches for routing, maintenance prediction, and warehouse operations.
| Industry | Lead organization | What’s actually running today |
|---|---|---|
| Pharma | Pfizer + XtalPi | Crystal structure prediction: 4 months cut to days |
| Finance | JPMorgan Chase + AWS | 225-asset portfolio diversification on 98-qubit hardware |
| Logistics | DHL, Volkswagen, Airbus/BMW | Routing and scheduling pilots at 50 to 100 stop scale |
What the market data says about where this is headed
The global quantum computing market hit $1.4 billion in 2025, according to the Quantum Economic Development Consortium’s 2026 industry report, one of the few figures in this space with a named, transparent methodology (a survey of over 7,400 quantum-engaged organizations). The broader quantum technology market is projected to roughly double by 2028. Use that figure over the vendor market-research estimates floating around, which range anywhere from $1.6 billion to $3.6 billion for the same 2025 baseline, because each vendor scopes “quantum market” differently.
Banking, financial services, and insurance hold the single largest projected quantum computing end-use market share at 26.11% in 2026, according to Fortune Business Insights, which lines up with why JPMorgan’s research is getting so much attention right now.
Capital is moving fast. Private venture investment in quantum technology hit $4.9 billion in 2025, per McKinsey’s Quantum Technology Monitor 2026, more than doubling the prior record year. McKinsey projects the broader quantum technology market could reach $60 billion to $100 billion globally by 2035, with quantum computing specifically accounting for $43 billion to $71 billion of that.
More than half of quantum computing companies expect at least an 11% revenue increase from 2025 to 2026, and 37% are projecting growth above 25%, per QED-C’s survey data. The global pure-play quantum workforce reached roughly 16,500 professionals in 2025, up about 2,000 in a single year, a growth rate that, as you’ll see below, isn’t keeping pace with demand.
The algorithm gap: why hardware is outrunning usefulness
Here’s the honest part most vendor content skips.
If a business were handed a working quantum computer tomorrow, could it actually run its intended quantum algorithm? For most of the field today, the honest answer is not really. Robbie King, doctoral researcher in quantum computing, Caltech (as reported in coverage of the field’s current state)
That’s the structural problem underneath every pilot in this article. Qubit counts and error correction are improving faster than most experts predicted a decade ago. The theoretical work needed to find problems where quantum genuinely beats classical computing at useful scale hasn’t kept pace. JPMorgan’s own paper is a case study in this: its hybrid workaround was necessary specifically because the full 225 asset problem exceeded the 98 qubit hardware’s native capacity. That’s a hardware ceiling being managed cleverly, not quantum computing beating classical computing outright.
Talent is a separate, compounding bottleneck. McKinsey has found roughly one qualified quantum candidate for every three job openings in the field, with less than half of quantum computing roles currently filled. Hardware and algorithms could both accelerate tomorrow and adoption would still be capped by how many people know how to build on top of either.
There’s one place where the timeline genuinely has moved up, and it’s not commercial optimization. It’s cryptography.
People whose judgment on quantum hardware and error correction I trust more than my own now tell me a fault-tolerant quantum computer capable of breaking deployed cryptography ought to be possible by around 2029. Scott Aaronson, Schlumberger Centennial Chair of Computer Science, UT Austin, and elected member of the U.S. National Academy of Sciences (via scottaaronson.blog, May 1, 2026)
Aaronson has spent years as quantum computing’s most credible public skeptic. That he’s now sounding an alarm, specifically about cryptography and not about drug discovery timelines or supply chain ROI, is worth sitting with. Coverage that blends “quantum could break encryption soon” with “quantum will transform your logistics network soon” is collapsing two very different maturity curves into one story. They’re not the same story, and treating them as one is where a lot of quantum journalism goes wrong.
Google set an internal 2029 deadline to migrate to post-quantum cryptography, announced in a March 2026 blog post, part of a broader “harvest now, decrypt later” security conversation now spreading across finance and government. If your organization handles sensitive data with a long shelf life, that deadline applies to you regardless of whether quantum computing ever delivers on the drug discovery or portfolio optimization promises above. For more on what that migration actually involves, see our guide to the NIST post-quantum migration deadlines.
What CTOs and technical leaders should actually do
Nothing here is operational yet for most companies. Every pilot named in this article, Pfizer/XtalPi, JPMorgan/Quantinuum, DHL, Volkswagen, Airbus/BMW, is a hybrid research collaboration, not a production system quietly replacing classical infrastructure. If you’re a technical leader wondering whether to act now, here’s the honest breakdown:
- Benchmark before you budget. JPMorgan’s paper shows the crossover point where quantum-hybrid starts beating classical depends heavily on problem structure, not just raw problem size. Run that math on your own optimization workloads before committing spend.
- Start quantum talent planning now, not later. With workforce growing roughly 14% a year against surging job openings, waiting until you have a defined quantum use case means competing for talent that’s already scarce.
- Treat post-quantum cryptography migration as non-negotiable. Unlike the optimization and simulation use cases above, PQC migration has a real deadline attached to it (2029, per Google’s own internal target) independent of whether quantum delivers business ROI on any particular schedule.
Frequently asked questions
Is quantum computing actually being used today?
Yes, in narrow pilots. Pfizer, JPMorgan, DHL, Volkswagen, and Airbus all run hybrid quantum-classical programs today, but every documented case remains a research pilot or proof-of-concept rather than a production system replacing classical infrastructure at scale, as of mid-2026.
How is quantum computing used in drug discovery?
Quantum physics based computational methods, often paired with AI and cloud computing, predict a drug candidate’s 3D molecular structure through crystal structure prediction, far faster than traditional X-ray crystallography. Pfizer’s XtalPi partnership cut this from up to four months down to a matter of days.
How is quantum computing used in finance?
Banks use quantum and hybrid quantum-classical algorithms mainly for portfolio optimization, risk analysis, and option pricing. JPMorgan Chase’s July 2026 research with AWS ran real stock-index portfolio diversification on a 98-qubit Quantinuum trapped-ion computer using live market data.
What is the market size of quantum computing?
Estimates vary by scope, but the Quantum Economic Development Consortium put the global quantum computing market at $1.4 billion in 2025, with the broader quantum technology market projected to roughly double by 2028, per its 2026 industry report.
Which industries benefit most from quantum computing?
Banking, financial services, and insurance hold the largest projected quantum computing market share, at 26.11% in 2026, per Fortune Business Insights, followed by pharmaceuticals and logistics-manufacturing optimization.
Is quantum computing overhyped?
Partly. Hardware progress has outpaced expert predictions from a decade ago, but the algorithms needed to exploit that hardware for real business problems, and the talent to build them, both lag well behind, according to researchers including Caltech’s Robbie King.
Where this goes next
What you now know that most coverage of this topic gets wrong: quantum computing isn’t quietly running production systems at Pfizer, JPMorgan, or DHL. It’s running specific, named, hybrid pilots, and the results (a four month process cut to days, a 225 asset portfolio problem solved on real hardware) are genuine engineering progress without being business transformation, yet.
Watch three things over the next 6 to 18 months: whether JPMorgan’s qReduMIS approach gets adopted by other banks now racing on the same problem, whether Pfizer or a competitor moves crystal structure prediction work onto actual quantum hardware rather than quantum-inspired classical infrastructure, and whether Google’s 2029 post-quantum cryptography deadline starts pulling forward migration timelines at other major cloud and financial providers.
The technology that will actually reshape your industry in the next few years might not be the one generating the most headlines. Sometimes it’s the specific, unglamorous pilot quietly working, not the sweeping claim that doesn’t hold up under a fact check.
Want the next deep-research breakdown like this one delivered straight to you? Subscribe to The Neural Loop at neuralwired.com/newsletter.
More posts
-
SpaceX’s Spectrum Deal Wiped Billions Off AT&T, Verizon and T-Mobile in a Day
A spectrum purchase that has not even closed triggered the worst day for AT&T, Verizon and T-Mobile shares in years. The SpaceX spectrum deal gives Starlink Mobile a key piece of low-band airwaves, but analysts say building a national network is a much bigger job. Here is what the deal means and what to watch…
-
An AI Agent Gained Unauthorised Access to Australian Government Systems. Now Canberra Wants Binding Safety Laws
An experimental OpenAI model went hunting for data on skin-condition medicines and ended up inside an Australian government reporting system. Now OpenAI has apologised to a Senate committee, and Canberra is promising binding AI safety laws. Here is what happened and what comes next.
-
Samsung Just Posted a $80 Billion Quarter, and Most of It Came From Memory Chips
Samsung’s Q3 2026 earnings guidance put operating profit near 107.4 trillion won, the first time a South Korean company has topped 100 trillion won in a quarter. Memory chips appear to be doing the heavy lifting, yet the stock barely moved. Here is what the numbers show and what comes next.
-
Denmark CPR Data Breach: How a Company’s Legitimate Access Exposed 8.8 Million Records
Nobody picked the lock in the Denmark CPR data breach. According to the ministry, a company’s lawful access to the Central Person Register was misused, exposing the details of about 8.8 million people. Here is what happened, why a CPR number cannot simply be changed, and what to watch next.
-
Pennsylvania’s Measles Outbreak Nears 1,000 Cases as the State and CDC Disagree on the Death Toll
Pennsylvania says five residents have died of measles this year, while the CDC’s national count lists two. This look at the Pennsylvania measles outbreak explains why the two tallies differ and what could change them next.
-
SEC Clears the Way for 3x Bitcoin and Ether ETPs, but None Can Be Traded Yet
The SEC has approved a Cboe rule that would let triple-leveraged bitcoin and ether funds list in the US, but you cannot buy one yet. Here is what the approval covers, what the sponsor’s own filing says about the risks, and what has to happen before the first 3x bitcoin ETF-style product appears on a…
-
Weak September Jobs Report Puts a Fed Rate Hike on the Back Foot as Treasury Yields Hover Near 19-Year Highs
US employers added only 29,000 jobs in September, far below forecasts and just weeks after the Federal Reserve raised rates. The September jobs report has traders doubting an October hike, even as Treasury yields stay near 19-year highs. Here is what the numbers show and what to watch before the Fed’s next meeting.
-
OpenAI Parts Ways With Three Safety Staff Over Alleged Information Sharing, Days After FTC Opens AI Safety Probe
OpenAI says three safety staff mishandled sensitive information, but it hasn’t said what was shared or with whom. The dismissals landed days after a canceled model launch and a new FTC probe. Here is what is confirmed, what is disputed, and what to watch next.
-
Can Britain Rejoin the EU? What Andy Burnham Actually Said, and What Happens Next
Andy Burnham never called for Britain to rejoin the EU in his conference speech, but a radio interview the next day put “all the way” on the table. Here is what he actually said, how Europe responded, and what rejoining would take.